Mark Massaro
Stock Analyst at BTIG
(4.41)
# 204
Out of 4,818 analysts
138
Total ratings
49.58%
Success rate
17.68%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Buy | $60 | $53.50 | +12.15% | 1 | Apr 21, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $7.89 | +14.14% | 5 | Dec 18, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $75 | $45.59 | +64.53% | 16 | Nov 26, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $4.25 | - | 8 | Sep 10, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $0.2 → $7 | $7.88 | -11.11% | 6 | Aug 23, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $3.83 | +82.77% | 1 | Aug 16, 2024 | |
| ZTS Zoetis | Maintains: Buy | $220 → $225 | $152.30 | +47.73% | 2 | Aug 12, 2024 | |
| NTRA Natera | Maintains: Buy | $125 → $135 | $154.48 | -12.61% | 13 | Aug 9, 2024 | |
| AKYA Akoya Biosciences | Downgrades: Neutral | n/a | $1.27 | - | 3 | Aug 6, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $35 → $45 | $109.03 | -58.73% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $50 | $47.33 | +5.64% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $440.98 | +31.53% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $10.10 | +108.02% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $2.83 | +182.69% | 3 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.65 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $1.73 | +362.43% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.05 | +162.30% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $20.92 | +43.40% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.85 | -14.53% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $25 | $18.50 | +35.14% | 2 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.36 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3.5 | $1.34 | +162.17% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $3.22 | +3,005.59% | 1 | Nov 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.56 | - | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $77.60 | +286.60% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $58.29 | -14.22% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $175.87 | -36.32% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $228.31 | -27.73% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $27.77 | +188.08% | 9 | Sep 10, 2018 |
Tempus AI
Apr 21, 2025
Initiates: Buy
Price Target: $60
Current: $53.50
Upside: +12.15%
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $7.89
Upside: +14.14%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $65 → $75
Current: $45.59
Upside: +64.53%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.25
Upside: -
Ginkgo Bioworks Holdings
Aug 23, 2024
Maintains: Sell
Price Target: $0.2 → $7
Current: $7.88
Upside: -11.11%
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $3.83
Upside: +82.77%
Zoetis
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $152.30
Upside: +47.73%
Natera
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $154.48
Upside: -12.61%
Akoya Biosciences
Aug 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.27
Upside: -
GeneDx Holdings
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $109.03
Upside: -58.73%
Jul 30, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $47.33
Upside: +5.64%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $440.98
Upside: +31.53%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $10.10
Upside: +108.02%
Mar 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $2.83
Upside: +182.69%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.65
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $1.73
Upside: +362.43%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $3.05
Upside: +162.30%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $20.92
Upside: +43.40%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.85
Upside: -14.53%
Feb 28, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $18.50
Upside: +35.14%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.36
Upside: -
Nov 18, 2022
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.34
Upside: +162.17%
Nov 30, 2020
Initiates: Buy
Price Target: $100
Current: $3.22
Upside: +3,005.59%
Oct 8, 2020
Initiates: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $77.60
Upside: +286.60%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $58.29
Upside: -14.22%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $175.87
Upside: -36.32%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $228.31
Upside: -27.73%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $27.77
Upside: +188.08%